Back to search

Article

Preventive Treatment With CGRP Monoclonal Antibodies Restores Brain Stem Habituation Deficits and Excitability to Painful Stimuli in Migraineurs: Results From a Prospective Case-control Study

2021-10-11

Abstract excerpt

<title>Abstract</title> <p>Background & ObjectivesCalcitonin gene-related peptide ligand/receptor (CGRP) antibodies effectively reduce headache frequency in migraineurs. It is understood that they act peripherally, which raises the question whether treatment merely interferes with the last stage of headache generation or, alternatively, causes secondary adaptations in the central nervous system and might thus pos...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b37b6802-520e-5c5e-9aa9-eec3df1ff35d
DOI
10.21203/rs.3.rs-951359/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preventive Treatment With CGRP Monoclonal Antibodies Restores Brain Stem Habituation Deficits and Excitability to Painful Stimuli in Migraineurs: Results From a Prospective Case-control StudyDOI 10.21203/rs.3.rs-951359/v1
Three-month treatment with monoclonal antibodies targeting the CGRP pathway is associated with multi-domain improvement of sensory processing and cortical network efficiency: results from a prospective case-control studySemantic proximity
Early Improvement of Affective, Fatigue and Allodynic Symptoms in a Cohort of Resistant Migraineurs Treated with Anti-CGRP/R AntibodiesSemantic proximity
Preventive CGRP ligand monoclonal antibody therapy in refractory adult-onset migraine- associated cyclic vomiting syndromeSemantic proximity
Systemic Calcitonin Gene-Related Peptide (CGRP) modifies auditory and vestibular end organ electrical potentials, and increases sensory hypersensitivitiesSemantic proximity
Anti-calcitonin Gene-Related Peptide Monoclonal Antibody Is Effective for Preventing Migraine Aura without HeadacheSemantic proximity
Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity
Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity
Cluster Headache and Migraine Shared and Unique Insights: Neurophysiological Implications, Neuroimaging, and Biomarkers: A Comprehensive ReviewSemantic proximity
Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity
Atogepant: Mechanism of action, clinical and translational scienceSemantic proximity
From CGRP to PACAP: Unraveling the Next Chapter in Migraine TreatmentSemantic proximity
Individual differences in endogenous pain modulation as a risk factor for chronic pain.Semantic proximity
Select a neighboring publication to make it the new centre.